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INTRODUCTION:  Angiomyolipoma  is the  most  common  benign  neoplasm  of  the  kidney.  Successful  trans-
plantation  of  an  AML  affected  kidney  has  been  reported.  However  it is  still  often  seen  as  a  contraindication
to  transplantation.
PRESENTATION  OF  CASE:  A 47-year-old  female  underwent  assessment  for a  direct  speciﬁed  kidney  dona-
tion to her  husband  who  had  end stage  renal  failure,  due  to  adult  polycystic  kidney  disease.  Routine
pre-operative  CT angiography  demonstrated  a  large  6 cm ×4 cm  AML  arising  from the  upper  pole  of  theidney
umour
ive donor transplantation
ngiomyolipoma
right  kidney.  Right-side  hand  assisted  retro-peritoneoscopic  live  donor  nephrectomy  with  bench  tumour
excision  was  subsequently  performed.  Recipient  implantation  was  unremarkable  with  no haemorrhage.
DISCUSSION:  Histology  conﬁrmed  a 7 cm  AML.  At  36  months  follow  up, the  recipient’s  serum  creatinine
was  158  mol/l  and  eGFR  40 ml/min  without  the need  for dialysis  at any  stage.
CONCLUSION:  AML  should  not  be a contraindication  for speciﬁed  live  kidney  donation,  despite  a  size of
7 cm.
ical A© 2012 Surg
. Introduction
Angiomyolipoma (AML) is the most common benign neoplasm
f the kidney.1 It is a tumour composed of variable amounts of
ature adipose tissue, smooth muscle, and vessels derived from
erivascular epitheloid cells. Its prevalence in the general pop-
lation has been reported to be between 0.1 and 0.22%.2 AML
ppears in two distinct settings; either associated with tuberous
clerosis or sporadic in nature. The clinical presentation of AML
s variable. Often patients are asymptomatic, however, they can
resent with the classic triad of ﬂank pain, a tender mass and
ross haematuria. They are commonly identiﬁed incidentally dur-
ng radiological investigations. These tumours have the potential
or life-threatening haemorrhagic rupture. In this setting patients
an present with sudden acute abdominal pain and haemorrhagic
hock. After renal cell carcinoma, AML  is the second most common
enal cause of retroperitoneal hemorrhage.3
AML’s can be diagnosed by ultrasound and computerised
omography (CT) imaging. It is important to differentiate an
ML  from renal carcinoma. AML  has a characteristic sonographic
ppearance of hyper echoic signal and acoustic shadowing.4 The
Abbreviations: AML, angiomyolipoma; CT, computerised tomography; eGFR,
stimated glomerular ﬁltration rate.
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CT diagnosis is conﬁrmed by the appearance of fat within the renal
lesion.
As a benign lesion that is frequently asymptomatic, AML  usu-
ally does not require any intervention. Indications for intervention
include suspicion of malignancy, haematuria, renal failure and rup-
ture. It has been demonstrated that tumour size (>4 cm) identiﬁed
on CT, is the most reliable predictor of rupture.1,5,6
Angiographic embolisation is the treatment modality of choice.
It has the advantage of preserving renal parenchyma and avoids the
risks associated with potentially major surgery.4 Failure of radio-
logical management in the acute setting may  necessitate total or
partial nephrectomy.
We present a case of a large AML  excised from a living donor
kidney, leading to successful transplantation and outcome for both
donor and recipient.
2. Presentation of case
A 54-year old pre-emptive transplant patient, suffering from
adult polycystic kidney disease was deemed suitable for transplan-
tation with his wife as a donor. His co-morbidities include obesity
with a BMI  of 30 (height 177 cm,  weight 93 kg), porphyria carrier
(with two previous deep vein thromboses) and treated hyperten-
sion. His pre-operative urea was  21.9 mmol/l, creatinine 349 mol/l
Open access under CC BY-NC-ND license.and estimated glomerular ﬁltration rate (eGFR) 14 ml/min.
His 47-year-old wife underwent assessment for living donation
with no contraindications. She had no signiﬁcant co-morbidities,
a BMI  of 23 (height 152 cm,  weight 52.5 kg), serum creatinine of
BY-NC-ND license.
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mig. 1. Donor right kidney after successful hand assisted retro-peritoneoscopic live
onor nephrectomy extraction demonstrating AML  in the upper pole.
5 mol/l and eGFR of more than 60 ml/min. Pre-operative CT
ngiography demonstrated a large 6 cm ×4 cm AML  arising from
he upper pole of the right kidney.
In addition to the routine consent procedure for a live donor
enal transplantation, the donor was also consented for rupture of
he AML, recurrence, possible graft damage and/or no transplanta-
ion.
The donor underwent a right-side hand assisted retroperito-
eoscopic live donor nephrectomy with ex vivo tumour excision
Figs. 1 and 2). The operative procedure was unremarkable. The
acroscopically tumour free resection margin was reviewed and
etrograde insufﬂation of methylene blue was used to identify calyx
esions. Two lesions were closed using PDS 5/0, followed by closure
f the resection surface using BioGlue (CryoLife Inc., USA) to achieve
aemostasis.
The recipient’s implantation involved a routine kidney trans-
lant approach to the external iliac vessels; reperfusion was
omogenic with no bleeding from the resection site.
The patient had prompt kidney graft function with a slow
ecline of creatinine. He was discharged from hospital on day 4
ost transplantation. His transplant ureteric stent was removed
 weeks after transplantation and he continued on maintenance
mmunosuppression with prednisolone 5 mg  daily and tacrolimus
 mg  twice a day.
At 36 months follow up, the donors creatinine and eGFRre 104 mol/l and 49 ml/min respectively. While the recipient’s
erum creatinine is 159 mol/l and eGFR 40 ml/min. In our depart-
ent, a routine 3-month biopsy is performed to diagnose early
Fig. 2. Excision of AML  from upper pole of donor kidney.PEN  ACCESS
urgery Case Reports 3 (2012) 594– 596 595
graft rejection. However, the patient is anticoagulated with war-
farin due to his previous history of multiple DVT’s. The routine post
transplant biopsy would therefore, only be indicated if the recipi-
ent’s renal function signiﬁcantly declined. This elevated creatinine
represents the donor/recipient weight mismatch.
Histology conﬁrmed a 7 cm benign AML  tumour, which was
larger than the CT angiographic ﬁndings.
3. Discussion
We  present a large AML  tumour excised from a direct speci-
ﬁed living donor kidney, prior to transplantation. The ﬁrst case of
a direct speciﬁed live donor kidney transplantation after ex vivo
excision of AML  was  performed in 1993.7 There have been sev-
eral reports of successful renal transplantation with AML  in situ.
In one case, the lesion was left in situ due to its small size and
central location.8 Follow up radiological studies of the lesion have
shown no further increase in size despite immunosuppression 18
months post operatively. There have been reports of ex vivo exci-
sion of AML  in cadaveric kidneys.9 Others have opted for an in vivo
excision of an AML  under cold ischaemia prior to nephrectomy and
transplantation.10 Proposed beneﬁts of in vivo excision include, the
ability to extensively evaluate the repair to the excision site at the
theoretical expense of an additional re-perfusion episode after cold
ischaemia. However we believe the ex vivo approach was more
favourable owing to the AML  size and location as it provided a
more controlled environment, i.e. no risk of bleeding during the
dissection. Cold ischaemia time is short in the live donor setting,
therefore not signiﬁcantly longer following the ex vivo dissection.
Radiological angiographic embolisation would have been an option,
however, after discussion with our radiology colleagues, it was
felt that the location and size made for a high risk of failure and
recurrence through this approach. Taking this into account we pro-
ceeded with a meticulous back table resection. Only the tumour
was excised, sparing all the renal parenchyma and avoiding the
complications associated with embolisation.
AML  has two recognised aetiologies; associated with the tuber-
ous sclerosis complex of pathologies or sporadic in nature. The
donor’s DNA was not examined for the presence of tuberous sclero-
sis due to the nature of her AML. In tuberous sclerosis, tumours are
often larger and affect multiple organs. There was  no evidence of
this on her pre-operative investigations. Furthermore in tuberous
sclerosis, AML’s are often bilateral and diagnosed in childhood or
early adult life.
The AML  affected kidney was utilised, which reduced the risk
of life threatening haemorrhage associated with large AMLs. The
donor was particularly happy to be helping her loved one whilst
also being treated simultaneously in one procedure.
Despite the high risk of rupture and intra-operative bleeding,
with careful pre-operative planning and meticulous intra-
operative care the removal of the AML  and direct speciﬁed kidney
transplantation was possible.
Advances in surgical management have helped to expand the
pool of potential organ donors. Kidneys previously considered
marginal or unsuitable due to benign lesions are now given con-
sideration.
4. Conclusion
As illustrated, large AML’s should not be an absolute con-
traindication for direct speciﬁed kidney transplantation. There
is no evidence in the literature to demonstrate recurrence post
direct speciﬁed kidney transplantation; however patients must
be consented for this possible complication. With careful assess-
ment within a multidisciplinary team, including nephrologists,
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ransplant surgeons, urologists, radiologists and histopathologists,
atients’ quality of life and prognosis can be signiﬁcantly improved.
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